Advertisement

Topics

Manhattan Scientifics Inc. Company Profile

18:00 EDT 26th September 2017 | BioPortfolio

Manhattan Scientifics Inc. (OTCBB: MHTX) is a pioneer in the field of nanomedicine technology transfer and commercialization. Focused on disruptive technologies for diagnostic, therapeutic and prosthetic purposes, Manhattan Scientifics is presently developing commercial medical prosthetics applications for its ultra fine grain metals, and plans to commercialize the cancer research work developed by Edward R. Flynn, PhD and Senior Scientific, LLC. The company is located in New Mexico, New York and Montreal. Additional information is available at www.mhtx.com.


News Articles [85 Associated News Articles listed on BioPortfolio]

Manhattan Scientifics, Inc. Announces Successful Completion Of Its Affiliate IPO

  Life Sciences Jobs   ...

Manhattan Scientifics Affiliate Files for Initial Public Offering on Australian Stock Exchange

Manhattan Scientifics Inc. (OTCQB: MHTX) is pleased to announce that its affiliate company, Imagion Biosystems Limited (“Imagion”), formerly known as Senior Scientific, LLC, f...

Manhattan Scientifics Schedules Investor Conference Call on Its Affiliate, Imagion Biosystems IPO

Manhattan Scientifics Inc. (OTCQB: MHTX) announced today that it will host a conference call for MHTX investors at 12:00 pm Eastern Time on Friday, June 16, 2017 to provide an upd...

Manhattan Scientifics, Inc. Affiliate Files For Initial Public Offering On Australian Stock Exchange

  Life Sciences Jobs   ...

Manhattan Scientifics Announces Successful Completion of its Affiliate Imagion Biosystems IPO

Imagion Biosystems (IBX) to Trade on the Australian (ASX) Stock Exchange Manhattan Scientifics Inc. (MHTX), Imagion Biosystems (IBX) and the National Institute of Healt...

Philadelphia as a laboratory for healthcare innovation: A conversation with Gary Kurtzman of Safeguard Scientifics

In his role as senior VP and managing director of Safeguard Scientifics, a venture capital firm based just outside Philadelphia, Gary Kurtzman leads the firm’s healthcare investment

First Manhattan Co. Has $226,000 Position in McKesson Corporation

First Manhattan Co. continued to hold its stake in shares of McKesson Corporation during the second quarter, Holdings Channel reports.

#jobs #lifescience Sales Representative – Manhattan, NY

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sales Representative – Manhattan, NY .NJ-South Plainfield, Want to be p...

Drugs and Medications [0 Results]

None

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

The Manhattan Frame Model - Manhattan World Inference in the Space of Surface Normals.

Objects and structures within man-made environments typically exhibit a high degree of organization in the form of orthogonal and parallel planes. Traditional approaches utilize these regularities via...

A Seer of Trump's Coming Parses Repeal and Replace.

Diana Furchtgott-Roth, a senior fellow at the Manhattan Institute, a freemarket think tank, confidently predicted back in October what few people saw coming-Donald Trump's electoral victory. Now she g...

Long-Term Exposure to Ambient Air Pollution and Subclinical Cerebrovascular Disease in NOMAS (the Northern Manhattan Study).

Long-term exposure to ambient air pollution is associated with higher risk of cardiovascular disease and stroke. We hypothesized that long-term exposure to air pollution would be associated with magne...

A Generative Approach to Chinese Shanshui Painting.

The Shan Shui in the World project recreated Manhattan, New York, in the style of traditional Chinese shanshui paintings by using a generative algorithm to transform its buildings into mountains. This...

Analysis of Traffic Crashes Involving Pedestrians Using Big Data: Investigation of Contributing Factors and Identification of Hotspots.

This study aims to explore the potential of using big data in advancing the pedestrian risk analysis including the investigation of contributing factors and the hotspot identification. Massive amounts...

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

Northern Manhattan Study of Metabolism and Mind

Pre-diabetes, type 2 diabetes, and their related conditions, adiposity and insulin resistance, are more prevalent in minorities Northern Manhattan compared to the general population of the...

Manhattan HIV/Hepatology Brain Bank

Description: The Manhattan HIV/Hepatology Brain Bank (MHBB) was established in 1998 as a resource for the AIDS research community. The MHBB was created to act as a center for the provisio...

Reducing Indoor Allergen Exposures in Northern Manhattan and the South Bronx

Controlled trial of an intervention to reduce indoor exposures to cockroach allergens among asthmatic children in NYC.

Does Statin Initiation Undermine Dietary Behavior?

The purpose of this research is to improve our understanding of the effects that taking cholesterol reducing pills have on dietary behavior as well as other health related behaviors

Northern Manhattan Diabetes Community Outreach Project

The objective of this study is to examine the effectiveness of a community health worker intervention at helping to control diabetes among Latinos with poorly controlled Type 2 diabetes. ...

Companies [68 Associated Companies listed on BioPortfolio]

Manhattan Scientifics Inc.

Manhattan Scientifics Inc. (OTCBB: MHTX) is a pioneer in the field of nanomedicine technology transfer and commercialization. Focused on disruptive technologies for diagnostic, th...

Manhattan Scientifics, Inc.

Manhattan Scientifics, Inc. operates with locations in New Mexico, New York, and Montreal. The company’s goal is to advance and commercialize disruptive technologies to creat...

Advanced Scientifics

Founded in 1985, Advanced Scientifics, is one of the leaders in the design and manufacture of disposable medical devices, bag systems and tubing assemblies for the pharmaceutical, biotechnology and me...

Safeguard Scientifics, Inc. and Quantia, Inc.

Founded in 1953 and based in the Greater Philadelphia area, Safeguard Scientifics, Inc. (NYSE:SFE) is celebrating 60 years of fostering innovation and entrepreneurship. Today, Saf...

First Manhattan Co.

First Manhattan Co. (“FMC”) was founded in 1964 and remains an owner-operated investment advisory firm. FMC is registered with the U.S. Securities and Exchange Commissio...

More Information about "Manhattan Scientifics Inc." on BioPortfolio

We have published hundreds of Manhattan Scientifics Inc. news stories on BioPortfolio along with dozens of Manhattan Scientifics Inc. Clinical Trials and PubMed Articles about Manhattan Scientifics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Manhattan Scientifics Inc. Companies in our database. You can also find out about relevant Manhattan Scientifics Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record